Increasing demand for minimally invasive surgeries, rapid advancements in surgical tools, & devices along with the growing incidence of chronic illness and...
Artivion Inc. (AORT), a cardiac and vascular surgery company specializing in aortic disease, is experiencing a banner year, with shares surging nearly 64% year-to-date to trade around $25.
The United States is analyzed to hold 83.5% share of the market in North America by 2034. The country is securing a significant share of regional market...
North America and Europe drive biosurgery market growth. North America, with a 5.64% CAGR, sees rising surgeries and approval of Cerament G in Canada. ...
The global regenerative medicine market is experiencing significant growth, attributable to the high adoption of stem cell technology, the increase in the...
/PRNewswire/ -- The "Global Transcatheter Devices Market (2023-2028) by Product, Application, and Geography, Competitive Analysis, Impact of Covid-19 and...
Growing prevalence of congenital heart disorders is expected to fuel the demand for pericardial patches. Increasing cases of hernias are anticipated to...
The global heart valve devices market is expected to increase due to advancements in structural heart systems as well as techniques including aortic valve...